ATE274910T1 - Transdermale vorrichtung zur verabreichung von testosteron oder einem derivat davon - Google Patents

Transdermale vorrichtung zur verabreichung von testosteron oder einem derivat davon

Info

Publication number
ATE274910T1
ATE274910T1 AT00929630T AT00929630T ATE274910T1 AT E274910 T1 ATE274910 T1 AT E274910T1 AT 00929630 T AT00929630 T AT 00929630T AT 00929630 T AT00929630 T AT 00929630T AT E274910 T1 ATE274910 T1 AT E274910T1
Authority
AT
Austria
Prior art keywords
testosterone
derivatives
self
administration
matrix layer
Prior art date
Application number
AT00929630T
Other languages
English (en)
Inventor
Michel Sournac
Laurent Liorzou
Joel Bougaret
Original Assignee
Pf Medicament
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pf Medicament filed Critical Pf Medicament
Application granted granted Critical
Publication of ATE274910T1 publication Critical patent/ATE274910T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/568—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A61K9/7061—Polyacrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Dermatology (AREA)
  • Epidemiology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Steroid Compounds (AREA)
AT00929630T 1999-05-19 2000-05-18 Transdermale vorrichtung zur verabreichung von testosteron oder einem derivat davon ATE274910T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9906367A FR2793689B1 (fr) 1999-05-19 1999-05-19 Dispositif transdermique pour l'administration de testosterone ou d'un de ses derives
PCT/FR2000/001345 WO2000071133A1 (fr) 1999-05-19 2000-05-18 Dispositif transdermique pour l'administration de testosterone ou d'un de ses derives

Publications (1)

Publication Number Publication Date
ATE274910T1 true ATE274910T1 (de) 2004-09-15

Family

ID=9545772

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00929630T ATE274910T1 (de) 1999-05-19 2000-05-18 Transdermale vorrichtung zur verabreichung von testosteron oder einem derivat davon

Country Status (10)

Country Link
US (1) US7018648B2 (de)
EP (1) EP1178806B1 (de)
AT (1) ATE274910T1 (de)
AU (1) AU4764800A (de)
CA (1) CA2374606C (de)
DE (1) DE60013431T2 (de)
ES (1) ES2226836T3 (de)
FR (1) FR2793689B1 (de)
PT (1) PT1178806E (de)
WO (1) WO2000071133A1 (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1080719A3 (de) * 1999-09-03 2001-04-25 Active Organics Inc. Verfahren zur Potenzierung der Wirksamkeit topischer Wirkstoffe durch Mono-acyl-(lyso)-glyceropholipide
US7364752B1 (en) 1999-11-12 2008-04-29 Abbott Laboratories Solid dispersion pharamaceutical formulations
EP1175205B1 (de) * 1999-11-12 2006-06-14 Abbott Laboratories Feste dispersion mit ritonavir, fenofibrat oder griseofulvin
DE10026698A1 (de) * 2000-05-30 2001-12-06 Basf Ag Selbstemulgierende Wirkstoffformulierung und Verwendung dieser Formulierung
US20040086551A1 (en) * 2002-10-30 2004-05-06 Miller Kenneth J. Fentanyl suspension-based silicone adhesive formulations and devices for transdermal delivery of fentanyl
US8377952B2 (en) * 2003-08-28 2013-02-19 Abbott Laboratories Solid pharmaceutical dosage formulation
US8025899B2 (en) 2003-08-28 2011-09-27 Abbott Laboratories Solid pharmaceutical dosage form
FR2895679B1 (fr) * 2005-12-29 2012-06-08 Pf Medicament Stabilisation de testosterone au sein de dispositifs transdermiques
US8147848B2 (en) 2009-08-26 2012-04-03 Allergan, Inc. Method for treating premature ejaculation with a botulinum neurotoxin
US20160256407A1 (en) * 2013-10-11 2016-09-08 Xep, Inc. Energy patch
JP6843741B2 (ja) * 2014-08-25 2021-03-17 ヘンケル アイピー アンド ホールディング ゲゼルシャフト ミット ベシュレンクテル ハフツング アクリル系ポリマーおよび経皮吸収型ドラッグデリバリーにおけるその使用

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4357934A (en) * 1980-07-23 1982-11-09 The Curators Of The University Of Missouri Method of treating male infertility
US5474783A (en) * 1988-03-04 1995-12-12 Noven Pharmaceuticals, Inc. Solubility parameter based drug delivery system and method for altering drug saturation concentration
AU622162B2 (en) * 1988-04-22 1992-04-02 Ciba-Geigy Ag Transdermal monolith systems
US5152997A (en) * 1990-12-11 1992-10-06 Theratech, Inc. Method and device for transdermally administering testosterone across nonscrotal skin at therapeutically effective levels
DE4117249C2 (de) * 1991-05-27 1998-05-14 Christian Dr Stief Linsidomin zur Behandlung erektiler Dysfunktionen
US5676968A (en) * 1991-10-31 1997-10-14 Schering Aktiengesellschaft Transdermal therapeutic systems with crystallization inhibitors
US5919478A (en) * 1993-06-25 1999-07-06 Alza Corporation Incorporating poly-N-vinyl amide in a transdermal system
JPH07328053A (ja) * 1994-06-03 1995-12-19 Tsuguto Kaieda 男性器ペニスの勃起力減退及び早漏性射精用薬剤塗布の避妊コンドーム及びその製造方法
DE19517145C2 (de) * 1995-05-10 2000-02-24 Hexal Pharmaforschung Gmbh Transdermales therapeutisches System (TTS) zur Verabreichung von Testosteron
US5693335A (en) * 1995-06-07 1997-12-02 Cygnus, Inc. Skin permeation enhancer composition for use with sex steroids
US5906830A (en) * 1995-09-08 1999-05-25 Cygnus, Inc. Supersaturated transdermal drug delivery systems, and methods for manufacturing the same
ATE226816T1 (de) * 1996-07-03 2002-11-15 Alza Corp Vorrichtungen zur arzneistoffabgabe und herstellungsverfahren
DE19701949A1 (de) * 1997-01-13 1998-07-16 Jenapharm Gmbh Transdermales therapeutisches System
HUP0001748A3 (en) * 1997-02-28 2001-03-28 Minnesota Mining And Mfg Co Sa Transdermal device for the delivery of testosterone
US6113940A (en) * 1997-03-03 2000-09-05 Brooke; Lawrence L. Cannabinoid patch and method for cannabis transdermal delivery
GB9800526D0 (en) * 1998-01-12 1998-03-11 Ciba Geigy Ag Organic compounds

Also Published As

Publication number Publication date
CA2374606C (fr) 2009-11-17
EP1178806A1 (de) 2002-02-13
EP1178806B1 (de) 2004-09-01
PT1178806E (pt) 2005-01-31
US20050100586A1 (en) 2005-05-12
WO2000071133A1 (fr) 2000-11-30
CA2374606A1 (fr) 2000-11-30
AU4764800A (en) 2000-12-12
DE60013431T2 (de) 2005-10-13
US7018648B2 (en) 2006-03-28
ES2226836T3 (es) 2005-04-01
FR2793689A1 (fr) 2000-11-24
DE60013431D1 (de) 2004-10-07
FR2793689B1 (fr) 2001-08-24

Similar Documents

Publication Publication Date Title
ATE274910T1 (de) Transdermale vorrichtung zur verabreichung von testosteron oder einem derivat davon
DE69717862D1 (de) Pharmazeutisches trägermittel, geeignet zur applikation pharmazeutischer verbindungen auf mucosale öberflächen
DE69814885D1 (de) Verfahren zur herstellung von arzneiformen mit kontrollierter wirkstoffabgabe auf polymerbasis
WO2004102457A3 (en) A personnel and process management system suitable for healthcare and other fields
DK1079813T3 (da) Farmaceutisk bæreranordning, der er egnet til administration af farmaceutiske forbindelser til slimhindeoverflader
ATE210432T1 (de) Transdermales therapeutisches system (tts) pergolid enthaltend
NO980277L (no) Hormonplaster
PT889723E (pt) Sistema terapeutico transdermico com pequena espressura da zona de aplicacao e elevada flexibilidade assim como processo de producao
AU2003225735A1 (en) Transdermal drug delivery patch system, method of making same and method of using same
DE69333607D1 (de) Vorrichtung zur Herstellung von vorgefüllten, sterilen Abgabevorrichtungen
ATE361977T1 (de) In vitro verfahren zur induzierung der regulierten pankreatische-hormon produktion in nicht-pankreatischen inselngeweben, damit verbundene pharmazeutische zusammenseztzungen
DE60234857D1 (de) Ausbildung von dünnfilmen auf substraten unter verwendung eines porösen trägers
WO2004000389A3 (en) Rapidly dissolving micro-perforator for drug delivery and other applications
DE69714448D1 (de) Verfahren zur herstellung von präparaten mit kontrollierter wirkstofffreisetzung auf basis von polymeren
DE602004030714D1 (de) Vorrichtung und verfahren zur weiterreichung auf der basis von dienstqualität
ATE223710T1 (de) Transdermales therapeutisches system (tts) zur verabreichung von sexualsteroidhormonen
MX2008010934A (es) Sistema terapeutico transdermico que contiene escopolamina.
ATE395050T1 (de) Transdermales therapeutisches system für die verabreichung carboxylgruppenhaltiger, nichtsteroidaler antiphlogistika, sowie verfahren zu seiner herstellung
ATE209912T1 (de) Transdermales therapeutisches system (tts) oxybutynin enthaltend
ATE135359T1 (de) Sulfoniumsalze und verfahren zu deren herstellung
DK1034780T3 (da) Tyndt betametason- og hyaluronsyrebehandlet hæfteplaster til behandling af psoriasis, dermatitis og dermatose
DK0825865T3 (da) Transdermalt, terapeutisk system for administrering af testosteron eller testosteronderivat
DE60303326D1 (de) Transdermalpflaster und Verfahren zu dessen Herstellung
DK0546389T3 (da) Piperidylmethylsubstituerede chromanderivater som virksomme stoffer til behandling af sygdomme i centralnervesystemet
DE50303832D1 (de) Abscheidungsverfahren für endoprothesen zur gleichmässigen medikamentenabgabe

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1178806

Country of ref document: EP